Literature DB >> 2140446

The enterochromaffin cells in the mouse gastrointestinal tract after streptozotocin treatment.

G M Portela-Gomes1, E Wilander, L Grimelius, R Bergström, G Ruhn.   

Abstract

Effects of 5 weeks streptozotocin treatment on the mouse gastrointestinal tract were studied with special emphasis on enterochromaffin (EC) cells. In the streptozotocin-treated animals the frequency of EC cells was reduced in the antral area and in the small intestine, but increased in the colon. The length of the intestinal tract and the mucosal thickness were increased in these animals. Possible mechanisms underlying these abnormalities of the EC cell system are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140446     DOI: 10.1016/S0344-0338(11)80544-3

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

1.  Antral endocrine cells in nonobese diabetic mice.

Authors:  M El-Salhy; A Spångéus
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

2.  Gastrointestinal endocrine cells in an animal model for human type 2 diabetes.

Authors:  A Spångéus; M Kand; M El-Salhy
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

3.  Cytotoxicity of streptozotocin on neuroendocrine cells of the pancreas and the gut.

Authors:  O Brenna; G Qvigstad; E Brenna; H L Waldum
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

Review 4.  The role of peptide YY in gastrointestinal diseases and disorders (review).

Authors:  Magdy El-Salhy; Tarek Mazzawi; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2012-12-21       Impact factor: 4.101

5.  Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats.

Authors:  Carlos Vinicius D da Rosa; Silvia C S F Azevedo; Roberto B Bazotte; Rosane M Peralta; Nilza C Buttow; Maria Montserrat D Pedrosa; Vilma A F de Godoi; Maria Raquel M Natali
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.